Kemiker at Acadia Pharmaceuticals

Hvidovre, Capital, Denmark

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years), Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, GastroenterologyIndustries

Requirements

Uddannet kemiker, farmaceut eller tilsvarende
Stor erfaring med analytisk kemi
Arbejder naturligt med GMP-regler og ved, hvordan de omsættes og implementeres i QC
Nogle års erfaring fra en tilsvarende rolle i et GMP-reguleret miljø
Dygtig til at give faglig sparring og fremkomme med brugbare hypoteser
Stærk kommunikativt i skrift og tale på både dansk og engelsk
Fordel: Flair og interesse for IT-laboratorie-løsninger og programmer
Ambitøs med naturlig sans og interesse for kvalitet
Positiv, engageret og bidrager med nye ideer, viden og læring

Responsibilities

Indgå i afdelingens daglige drift og supportere/godkende analyser i samarbejde med teamet
Udarbejde afvigelser
Opdatere SOP'er
Vedligeholde kvalitetssystemer
Arbejde med daglig trouble-shooting i forbindelse med afvigelses- og OOS-undersøgelser
Analysere råvarer, mellemprodukter og færdigvarer (kemiske analyser efter pharmakopéer ved hjælp af HPLC, GC, ICP, UV, IR m.m.)
Rapportere data i GLIMS
Dele viden og erfaring med kolleger for kontinuerlige forbedringer af QC-processer

Skills

GMP

cGMP

analytisk kemi

pharmakopéer

kemiske analyser

API

Quality Control

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.

Potential clinical trial delays could affect drug approval timelines.

Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.

The company has a strong R&D foundation, developing innovative small molecule drugs.

Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.

Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.

The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI

Try Jobo Free